, Consumer Class Action Lawsuit & Settlement News, Coronavirus Legal News & Class Action Lawsuits, California Mortgage Lender Consumer Protection. Reports have surfaced that certain types of MRI contrast agents can cause serious cognitive and nervous system problems – even in patients with normal kidney function. Call us today – we’re here to assist you in every way possible. By clicking the button you accept our disclaimer and privacy policy. The plaintiff, Candice D., says she was injected with the gadolinium dye Optimark for MRIs in January 2013. February 24, 2019 – Researchers from Finland, led by Dr. Aida Kiviniemi, found that gadolinium deposits can be detected in both enhancing and non-enhancing gliomas, adjacent normal brain tissue, and necrosis. Though Candice expected the gadolinium dye to leave her body quickly after use, she alleges it was “retained permanently or indefinitely in multiple organs and soft tissues.” Now, years later, she says the dye remains. It has many uses, but one of the most common is as a contrast agent for magnetic resonance imaging (MRI) and other scans. Basically, large magnets are turned on and off rapidly during the test. Some of the MRI cases already went to trial, such as one that resulted in a $5 million verdict against GE Healthcare in 2013 (the plaintiff, however, died shortly after the trial was over). This field is for validation purposes and should be left unchanged. If you had Gadolinium storage condition or Gadolinium deposition disease, contact our lawyers for lawsuit info at (866) 920-0753. Patients claim that, instead of leaving the body quickly after use, the gadolinium dye has stayed in their bodies for months or even years afterward, leading to further problems. They’re now suing 11 separate makers of these contrast dyes in a $10 million lawsuit. Since the late 1980s, gadolinium has been used in some contrast dyes because of its strong paramagnetic properties, which react to the magnetic resona… During an MRI scan, a gadolinium contrast dye is often injected intravenously to enhance the imaging of the scan. What is Gadolinium Contrast Dye? By Jane Mundy: Health Canada says gadolinium, the contrast agent used in MRI imaging, can build up in the brain, but won’t call it harmful. An Arizona woman has filed a new lawsuit, alleging that the gadolinium contrast dye used during her MRI scan stayed in her body long after the scan was... Read More, © 2020 Top Class Actions LLC. A new MRI contrast dye lawsuit claims gadolinium retention from Optimark and Multihance caused an Arizona woman to suffer severe injuries, including fibrosis in her organs, bones, and skin. The complaint was filed in San Francisco on May 28, 2019. Gadolinium Lawsuit. are no longer reviewing additional Gadolinium MRI Contrast lawsuits. A review has found that low levels of gadolinium can be retained in the brain and other tissues after administration of gadolinium-containing contrast agents (GdCAs). While gadolinium-based contrast agents (GBCAs) have long been recognized as critical components of MRI, the pharmacokinetics, pharmacodynamics and potential toxicity of these agents are under increasing scrutiny, particularly with reports that gadolinium can accumulate in the brain after contrast enhanced MRI examinations. July 25, 2018 - The FDA approved an updated label for Magnevist, a type of contrast agent. The Gadolinium in Humans paper from the American Journal of Radiology is included in the lawsuit filed in San Francisco. February 24, 2019 – Researchers from Finland, led by Dr. Aida Kiviniemi, found that gadolinium deposits can be detected in both enhancing and non-enhancing gliomas, adjacent normal brain tissue, and necrosis. Friday, May 10, 2019: FDA Approved Magnevist Alleged For Multiple Organ Damages. If you or a loved one developed gadolinium toxicity after having an MRI with gadolinium contrast, you may be eligible to file a gadolinium MRI lawsuit against pharmaceutical companies. Despite being marketed for decades as a safe product, this substance has been recently found to be associated with severe toxicity.